"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market Size and Share Analysis Report During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Accomplishment of maximum return on investment (ROI) is one of the most wannabe goals for any industry which...

  Introduction The world of healthcare is experiencing a tectonic shift, fueled by biotechnology advances and personalized medicine. The epicenter of this revolution is Monoclonal Antibody Therapeutics (mABs) laboratory-created molecules with the ability to mimic human antibodies. These biologics are revolutionizing the way we combat cancer, autoimmune diseases, infectious diseases, and...